IL162619A0 - Piperidine-2,6-diones that are heterocyclically substituted in position 3 - Google Patents

Piperidine-2,6-diones that are heterocyclically substituted in position 3

Info

Publication number
IL162619A0
IL162619A0 IL16261902A IL16261902A IL162619A0 IL 162619 A0 IL162619 A0 IL 162619A0 IL 16261902 A IL16261902 A IL 16261902A IL 16261902 A IL16261902 A IL 16261902A IL 162619 A0 IL162619 A0 IL 162619A0
Authority
IL
Israel
Prior art keywords
diones
piperidine
heterocyclically substituted
heterocyclically
substituted
Prior art date
Application number
IL16261902A
Other languages
English (en)
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of IL162619A0 publication Critical patent/IL162619A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16261902A 2001-12-21 2002-12-18 Piperidine-2,6-diones that are heterocyclically substituted in position 3 IL162619A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10163595A DE10163595A1 (de) 2001-12-21 2001-12-21 In 3-Position heterocyclisch substituierte Piperidin-2,6-dione
PCT/EP2002/014447 WO2003053956A1 (de) 2001-12-21 2002-12-18 In 3-position heterocyclisch substituierte piperidin-2,6-dione

Publications (1)

Publication Number Publication Date
IL162619A0 true IL162619A0 (en) 2005-11-20

Family

ID=7710600

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16261902A IL162619A0 (en) 2001-12-21 2002-12-18 Piperidine-2,6-diones that are heterocyclically substituted in position 3

Country Status (27)

Country Link
US (1) US7183274B2 (xx)
EP (1) EP1456197B1 (xx)
JP (1) JP2005516953A (xx)
KR (1) KR20040068325A (xx)
CN (1) CN1620448A (xx)
AR (1) AR037963A1 (xx)
AT (1) ATE355285T1 (xx)
AU (1) AU2002364286A1 (xx)
BR (1) BR0215337A (xx)
CA (1) CA2471079A1 (xx)
CY (1) CY1106540T1 (xx)
DE (2) DE10163595A1 (xx)
DK (1) DK1456197T3 (xx)
EC (1) ECSP045161A (xx)
ES (1) ES2282514T3 (xx)
HU (1) HUP0402477A2 (xx)
IL (1) IL162619A0 (xx)
MX (1) MXPA04006120A (xx)
NO (1) NO20042946L (xx)
NZ (1) NZ533995A (xx)
PE (1) PE20030745A1 (xx)
PL (1) PL371028A1 (xx)
PT (1) PT1456197E (xx)
RU (1) RU2004122633A (xx)
SI (1) SI1456197T1 (xx)
WO (1) WO2003053956A1 (xx)
ZA (1) ZA200405780B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026703A1 (de) * 2004-05-28 2005-12-29 Grünenthal GmbH Verfahren zur Herstellung von in 3-Position heterocyclisch substituierten Piperidin-2,6-dionen
DE102005057912A1 (de) 2005-12-02 2007-07-19 Grünenthal GmbH In 3-Position heterocyclisch substituierte Pyrrolidin(thi)one
KR200484781Y1 (ko) 2017-07-04 2017-10-25 김정래 지퍼손잡이 보호장치

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652871B1 (en) * 1992-07-29 2001-10-17 MERCK SHARP & DOHME LTD. Benzodiazepine derivatives
JPH09500134A (ja) * 1993-07-16 1997-01-07 メルク エンド カンパニー インコーポレーテッド ベンゾオキサジノンおよびベンゾピリミジノンピペリジニル早産防止オキシトシン受容体拮抗剤
DE19843793C2 (de) * 1998-09-24 2000-08-03 Gruenenthal Gmbh Substituierte Benzamide
WO2000072836A2 (en) 1999-05-27 2000-12-07 The Rockefeller University Methods of promoting or enhancing interleukin-12 production through administration of thalidomide
US6767926B1 (en) * 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
DE19957342A1 (de) 1999-11-29 2001-05-31 Gruenenthal Gmbh Verfahren zur Behandlung und/oder Prophylaxe von IL-12-bedingten Erkrankungen
DE10002509A1 (de) * 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
DE10250082A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
PE20030745A1 (es) 2003-09-05
NZ533995A (en) 2006-11-30
WO2003053956A1 (de) 2003-07-03
CY1106540T1 (el) 2012-01-25
DE50209613D1 (de) 2007-04-12
CA2471079A1 (en) 2003-07-03
PL371028A1 (en) 2005-06-13
EP1456197B1 (de) 2007-02-28
RU2004122633A (ru) 2005-06-10
HUP0402477A2 (hu) 2005-05-30
KR20040068325A (ko) 2004-07-30
BR0215337A (pt) 2004-11-16
ATE355285T1 (de) 2006-03-15
ZA200405780B (en) 2005-07-26
DK1456197T3 (da) 2007-06-11
SI1456197T1 (sl) 2007-08-31
MXPA04006120A (es) 2004-11-01
CN1620448A (zh) 2005-05-25
JP2005516953A (ja) 2005-06-09
AR037963A1 (es) 2004-12-22
PT1456197E (pt) 2007-03-30
EP1456197A1 (de) 2004-09-15
ES2282514T3 (es) 2007-10-16
DE10163595A1 (de) 2003-08-07
NO20042946L (no) 2004-09-20
AU2002364286A1 (en) 2003-07-09
US7183274B2 (en) 2007-02-27
ECSP045161A (es) 2004-08-27
US20050020581A1 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
IL153224A0 (en) 1,4-dihydropyridines as bradykinin antagonists
EP1451173A4 (en) PIPERIDINE
ITTO20000976A0 (it) Composizioni acaricide.
TW454659U (en) Tool shelf
GB0108099D0 (en) Aminopiperidine derivatives
MXPA03005743A (es) Antagonistas muscarinicos.
ZA200500065B (en) Crystalline 2,5,-dione-3-(1-methyl-1H-indol-3-yl)-Ä1-(pyridin-2-ylmethyl)piperidin-4-ylÜ-1H-indol-3-ylÜ-1H-pyrrole mono-hydrochloride
GB2361235B (en) 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides
MXPA03007848A (es) Derivados de quinolil propil piperidina, su preparacion y las composiciones que los contienen.
MXPA03006991A (es) Derivados de piperidina como antagonistas de neurocinina 1.
IL154422A0 (en) Paroxetine compositions and processes for making the same
MXPA03008896A (es) Indolinonas sustituidas en posicion 6, su preparacion y su utilizacion como medicamentos.
IL154675A0 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
GB0113342D0 (en) Novel Heterocycles 1
MXPA01011743A (es) Arilpirimidinas substituidas 5-.
PL370715A1 (en) [1.2]-oxazin-3,5-diones
GB0113344D0 (en) Novel heterocycles 3
IL162619A0 (en) Piperidine-2,6-diones that are heterocyclically substituted in position 3
GB0113343D0 (en) Novel Heterocycles 2
GB2367050B (en) Beam lifter
ZA200205310B (en) Table top.
GB0103651D0 (en) Extension bar
IT1320878B1 (it) Armadietto portautensili .
HK1057551A1 (en) Substituted 3,4-dihydro-pyridoÄ1,2-AÜpyrimidines.